AOHC Encore 2024-316 Lessons Learned from a Hazardous Medication Surveillance Program in Healthcare

316 Lessons Learned from a Hazardous Medication Surveillance Program in Healthcare

Video Transcription

Video Summary

The video transcript features a discussion on the Lessons Learned from Hazardous Medication Surveillance Program, focusing on medical surveillance for those handling hazardous medications. It highlights the potential health effects of exposure to these medications, the recommendations from NIOSH, and the US Pharmacopeia's USP 800 chapter. The program emphasizes the need for surveillance, including baseline clinical evaluation and regular monitoring, while also addressing challenges such as over-testing. The presenter shares their experience implementing the program, including criteria for enrollment, baseline surveillance, and staff education. The audience engages with questions and comments related to risk assessment, baseline testing, spill exposures, and the importance of data analysis and legal protection. The discussion also touches on the potential for more precise biomonitoring tools in the future.

Keywords

Lessons Learned

Hazardous Medication Surveillance Program

Medical Surveillance

Health Effects

NIOSH Recommendations

US Pharmacopeia USP 800

Baseline Clinical Evaluation

Regular Monitoring

Challenges